Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells become highly resistant to treatment after developing mutations in a key gene ...

From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...

When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer grows.

Large cell carcinoma is aggressive, requiring early detection through imaging and biopsy for optimal treatment outcomes.

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...

UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the ...

Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

Small cell lung cancer (SCLC) and other neuroendocrine tumors (NETs) are a group of cancers that originate from neuroendocrine cells, which release hormones into the bloodstream when they receive ...

Small cell lung cancer (SCLC) is a fast-growing cancer that develops in cells within the lung. A range of medical tests and procedures are available to help doctors diagnose SCLC and create an ...